The European Commission (EC) will now review the CHMP recommendation, and a decision on the label extension application of IXCHIQ ® in the European Union (EU), Norway, Liechtenstein and Iceland is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback